AI Screening AI Chat Pricing

D.Western Therapeutics Institute, Inc.【JP:4576】Balance sheet

Market cap

¥4.5B

P/E ratio

-6.7x

De Western Therapeutics Institute develops protein kinase inhibitor drugs for eye diseases and licenses them to pharmaceutical companies for commercialization.

Summary Financials Dividends History Ownership Workforce

Income statement Balance sheet Cash flow Other

	2013/12	2014/12	2015/12	2016/12	2017/12	2018/12	2019/12	2020/12	2021/12	2022/12	2023/12	2024/12	2025/12
Cash and cash equivalents	-	1,447	1,747	2,292	2,133	1,584	1,541	2,308	1,934	2,335	1,867	1,126	1,669
Marketable securities, current	-	620	183	353	-	-	-	-	-	-	-	-	-
Total cash & short-term investments	-	2,067	1,930	2,645	2,133	1,584	1,541	2,308	1,934	2,335	1,867	1,126	1,669
Total current assets	-	2,109	2,025	2,776	2,516	1,764	1,716	2,503	2,162	2,659	2,138	1,475	1,978
Property, plant and equipment, net	-	6	5	25	15	5	3	5	5	10	10	11	10
Marketable securities, non-current	-	12	100	101	11	5	5	13	123	154	142	143	143
Total non-current assets	-	27	115	136	362	309	266	234	301	297	235	194	151
Total assets	-	2,136	2,140	2,913	2,877	2,074	1,981	2,738	2,463	2,956	2,373	1,669	2,129
Long-term debt, current	-	-	-	-	-	120	120	120	130	120	10	19	99
Total current liabilities	-	19	27	36	156	268	189	210	193	211	194	133	201
Total non-current liabilities	-	-	-	-	625	505	384	364	234	872	900	803	530
Total liabilities	-	19	27	36	782	774	573	574	428	1,083	1,094	936	731
Retained earnings	-	-2,607	-2,904	-3,157	-4,721	-908	-775	-1,051	-1,200	-1,630	-2,442	-3,733	-622
Stockholders' equity	2,269	2,116	2,113	2,877	2,096	1,300	1,408	2,164	2,035	1,873	1,280	734	1,435

Raw aggregated data